Trial Profile
A comparison study of ondansetron and palonosetron for the prevention of postoperative nausea and vomiting in women patients using intravenous patient-controlled analgesia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary) ; Ondansetron
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 28 Feb 2018 Status changed from recruiting to completed.
- 18 Sep 2013 New trial record